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Abstract 
Background: Many people in Australia consult pharmacists as the first point of 
contact when seeking medical advice, therefore it is important that the pharmacist can 
appropriately decide whether to provide an over-the-counter treatment or advise a 
consultation with a doctor. 
Methods: A questionnaire was administered to clients at eighteen community 
pharmacies in Perth, Western Australia over 15 weeks. Seventy-four clients seeking 
over-the-counter treatment for haemorrhoids were invited to complete an anonymous, 
previously validated questionnaire based on symptoms of colorectal disease. 
Results: A response rate of 63.5% was recorded; respondents had a mean age of 43 
years. More than half the respondents presented with rectal bleeding, the majority 
indicating that the blood was mixed with the stool. 40% of respondents indicated that 
they had experienced a change in bowel habit, which had persisted for over a month 
in most (66.7%) cases. Twenty percent of those surveyed presented with slime and / 
or blood in their bowel motion, and almost one in three presented with abdominal 
pain. Respondents’ attitudes to completing the questionnaire were overwhelmingly 
positive. Australasian Medical Journal 2009,1,2 
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Conclusions: The symptomatic profiles of clients who present with anorectal 
symptoms suggest that there are a significant proportion of clients who may benefit 
from medical consultation to rule out underlying conditions such as colorectal cancer. 
Responses from participants also suggest that the questionnaire model for obtaining 
symptomatic information from clients is a useful and acceptable intervention in a 
community pharmacy setting. 
Background 
In Australia, community pharmacists are amongst the most highly accessible health 
professionals. Whilst the traditional role of the pharmacist has been the dispensing of 
medicines on prescription, this is expanding ever rapidly into the provision of primary 
health care.
1,2,3 Pharmacists frequently advise people about health concerns because 
there is no charge for pharmacist advice, and there is no requirement to make an 
appointment so waiting times are minimal.
1,4 Primary care in a community pharmacy 
setting includes the sale of non-prescription medicines (unscheduled, ‘pharmacy’ or 
‘pharmacist only’ medicines),
1,2 provision of general health information and advice,
1,5 
and referral to other health care professionals where appropriate.
1,5 Referral, 
especially to general practitioners, is of importance because community pharmacy 
customers may fail to recognise the importance of many signs and symptoms, and the 
pharmacist frequently has to review the suitability of product requests.
5 Community 
pharmacy customers may request either specific products or products to treat specific 
symptoms, and it has been demonstrated that both product-based and symptom-based 
requests are often inappropriate, often requiring the pharmacist to suggest other 
treatments or courses of action.
6 This is especially true in the case of potentially life-
threatening conditions. 
The symptoms associated with haemorrhoids are often non-specific and can be 
attributed to a wide range of gastrointestinal conditions, with colorectal cancer as a 
key differential diagnosis.
7, 8, 9 The prognosis for colorectal cancer deteriorates with 
later detection, therefore it is important that early signs are recognised and the 
customer referred for further medical investigation when indicated. The Royal 
Pharmaceutical Society of Great Britain practice guidelines outline a number of 
trigger points for referral of clients with colorectal symptoms, including rectal Australasian Medical Journal 2009,1,2 
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bleeding; persistent change in bowel habit, especially looser motions; abdominal pain; 
a right sided abdominal mass and unexplained iron deficiency anaemia.
10 There are no 
equivalent practice guidelines published by an official body in Australia. Specific 
anorectal symptoms are strongly associated with colorectal cancer, for example an 
increased frequency of bowel motions that is worse in the morning has a relative risk 
of 2.32 for colorectal cancer.
11 These symptoms may often be self-treated by 
customers using products available in pharmacies. As such, the pharmacist needs to 
obtain an adequate amount of symptomatic information to determine which treatment, 
if any, is appropriate, and refer where further medical investigation is warranted. 
It has been shown by Evans MJ et al. (2005) and Lohrisch D et al. (1978) that 
pharmacists do have the necessary knowledge and skills to decide whether to treat or 
refer symptomatic customers.
12, 13 However, this study aims to determine the 
proportion of community pharmacy customers who present with significant 
symptoms. 
Clients who suffer from haemorrhoids will typically present with symptoms such as 
rectal bleeding, sensation of incomplete evacuation following a bowel motion and 
local irritation and itching.
9 The development of haemorrhoids may be preceded by 
constipation.
9 Symptoms of colorectal cancer include persistent rectal bleeding, a 
change in bowel habit, abdominal cramping, faecal urgency and unexplained iron 
deficiency anaemia.
14 These symptoms are similar and it may only be the detail of 
symptoms that differentiates them. For example, a small quantity of blood that is seen 
only on the toilet paper following a bowel motion is likely to be a result of 
haemorrhoids, but blood mixed with the stool warrants further investigation. Clients 
who report suffering from constipation are at a lower risk of colorectal cancer than 
those with diarrhoea, or alternating diarrhoea and constipation. 
9, 10,11,14,15  
Haemorrhoids may be considered an embarrassing condition. Previous studies  have 
focused on similar embarrassing problems such as  vulvovaginal candidiasis..
16 They 
suggest that many people, are likely to be reluctant to disclose their symptoms, 
especially in the detail that is necessary for health care professionals to make 
appropriate recommendations.
17,18 Whilst some people are uncomfortable discussing 
personal issues such as their health in the setting of a community pharmacy, it has Australasian Medical Journal 2009,1,2 
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been shown that most people trust their local community pharmacist, feel that their 
privacy is well maintained, and often demonstrate considerable trust in all pharmacy 
staff.
18,19 In a 2006 Reader’s Digest survey, pharmacists ranked fifth on a list of the 
most trusted professions, and trust has been cited as the primary reason that people 
seek information from pharmacists.
20,21 This study aims to determine the attitudes of 
pharmacy customers to completing written questionnaires about their anorectal 
symptoms. 
The use of written materials and screening methods in a community pharmacy setting 
has been previously successfully evaluated.
22, 23, 24 It was hypothesised that a survey 
of clients with colorectal symptoms could be used to screen for clients at risk of 
colorectal cancer. Colorectal cancer is currently one of the most prevalent cancers in 
Australia, and is also responsible for 12-13% of cancer related deaths.
25 Current 
screening methods involve participant using a faecal occult blood test and ensuring 
regular colonoscopies are performed for people with risk factors.
14,26 However, clients 
who are not eligible to participate in the national bowel screening program would 
particularly benefit from close questioning when presenting to a pharmacy with 
colorectal symptoms. 
The use of written materials to screen for several chronic or life-limiting diseases in 
community pharmacy have been studied, and in many instances these written 
materials have been used when referring these clients to general practitioners.
27 Given 
that clients had already taken the time to complete a detailed symptom-based 
questionnaire, it was thought that this questionnaire could be incorporated into a 
referral process for at-risk clients. The extent to which clients would agree to 
community pharmacists passing this information to their general practitioner is not 
clear and requires further investigation. 
The objectives of this study were to determine: 
•  whether there are community pharmacy customers who present with anorectal 
conditions that would benefit from detailed questioning regarding their 
symptoms; Australasian Medical Journal 2009,1,2 
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•  whether certain customers who request treatment for anorectal conditions 
present with risk factors and specific symptoms associated with colorectal 
cancer, or other serious conditions; 
•  the acceptability of a written symptom-based questionnaire within a 
community pharmacy setting; and 
•  the potential for the utilisation of written materials in a more formalised 
referral process to general practitioners. 
Methods 
Ethical approval for the project was obtained from the Curtin University of 
Technology Human Research Ethics Committee (PH-06-2007). 
The questionnaire used in this study is known as the Patient Consultation 
Questionnaire (PCQ). It is a validated survey previously administered to patients in 
the United Kingdom prior to attending a specialist colorectal clinic. The PCQ is a 60-
item questionnaire of colorectal symptoms (combinations of symptoms, if any, their 
duration and their progression) and medical and family history.
15 The questionnaire 
was shown to have both high specificity and sensitivity, and a high numerical 
weighted score generated from the results had a strong association with colorectal 
cancer, and also other serious colorectal conditions such as inflammatory bowel 
disease and diverticular disease.
15 For the purposes of this research, the survey also 
included a number of questions relating to the participants’ attitudes to completing the 
questionnaire. 
As this was a student project with limited resources the survey excluded questions on 
family history such that it was not possible to determine a ‘risk score’ for each 
respondent and therefore formally identify those who were at highest risk of 
colorectal disease. Had it been possible to identify these people there would have been 
an ethical obligation to follow up the cases with a cost to the researcher.  
A convenience sample of community pharmacies in the Perth metropolitan area were 
recruited to participate in this study and agreed to distribute the PCQ to customers.  Australasian Medical Journal 2009,1,2 
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Staff at participating pharmacies was informed that any customer who requested 
treatment for haemorrhoids or anorectal symptoms indicative of haemorrhoids should 
be invited to be included in the study. Clients under the age of 18, or who were 
otherwise unable to give informed consent, were excluded.  
Pharmacy staff was visited by the student approximately once a week to collect 
completed surveys and discuss informal observations made by pharmacists about the 
study. 
At the end of the data collection period consisting of a total of fifteen weeks, all 
remaining surveys were collected from participating pharmacies. Data from the 
completed questionnaires was entered into Microsoft Excel for Windows® using 
numerical coding for responses. The data was then analysed using SPSS for 
Windows®. 
Results 
Seventy four people were invited to participate in the survey. Forty-seven completed 
surveys were received. The response rate was therefore 63.5%. Over half (51.1%) of 
the clients surveyed had presented with rectal bleeding. In the majority of cases 
(82.6%), the blood was reported as fresh or bright, however one patient indicated that 
the blood was old or dark, and three clients reported a mixture of both. Of those who 
reported rectal bleeding, 11 (47.8%) stated that the blood was seen on the toilet paper 
only. Two people reported that the rectal bleeding was mixed with the stool. Six 
people with rectal bleeding indicated that a large amount of blood was seen in the 
stool. See Figure 1. Australasian Medical Journal 2009,1,2 
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Figure 1. Location of rectal bleeding as described by respondents 
Forty percent of respondents reported experiencing a change in bowel habit.  In this 
study, 38.1% of people with an altered bowel habit indicated that they had suffered 
from diarrhoea, consisting of 17.8% of the total sample. Six respondents indicated 
that there was an increased frequency of bowel motions that was worse in the 
morning. Another 38.1% indicated that they suffered from constipation. The 
remaining 14.3% indicated that they had suffered from alternating diarrhoea and 
constipation.  See Figure 2. 
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Figure 2. Bowel habit changes as described by respondents
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Only 10 out of the 23 (43.5%) clients who presented with rectal bleeding had sought 
treatment within a month of the onset of symptoms. Three clients reported that the 
rectal bleeding had been present for between six and twelve months, two stated that 
they had noticed bleeding for one to two years, and five out of the twenty-three clients 
who presented with rectal bleeding had experienced symptoms for over two years. 
Similarly, two thirds of clients who presented with altered bowel habit had suffered 
from symptoms for over a month, with 7 respondents (15.6% of the total sample) 
indicating that the change had been present for over two years. See Figure 3. 
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Figure 3. Duration of presence of rectal bleeding 
Forty percent of respondents in this study had not sought the advice of a general 
practitioner before presenting to the community pharmacy with symptoms. Many of 
these presented with “red flag” symptoms that warrant further investigation, including 
two with blood mixed with the stool and four with a persistent change in bowel habit.  
Thirteen people (28.9%) who participated in this study presented with abdominal 
pain. Eleven of these people also indicated that they suffered from bloating. 
Unexplained weight loss was present in eight respondents (17.8%) and a loss of 
appetite was reported in five (11.1% of the total sample). Australasian Medical Journal 2009,1,2 
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Eighteen of the forty-five clients who requested haemorrhoid products indicated that 
they were taking some form of regular medication, as shown below in figure 4. 
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Figure 4. Medications taken by survey respondents 
Several pharmacists mentioned during this study that people are frequently 
embarrassed when seeking haemorrhoid treatment, and may be reluctant to discuss 
their symptoms. 73.3% of respondents indicated that they would prefer to complete 
the questionnaire without assistance, with only 13.3% preferring the help of pharmacy 
staff.  
86.7% of respondents indicated that the questionnaire was easy to complete. Thirteen 
respondents (28.9%) strongly agreed, and twenty-one respondents (46.7%) agreed that 
they were comfortable completing the questionnaire. The importance of privacy was 
highlighted as 75.6% of respondents indicating on a Likert scale, that it was important 
that they were able to complete the questionnaire in a quiet or private area. 66.7% of 
respondents also indicated that they were more comfortable completing written 
symptom based questionnaires than discussing their anorectal symptoms verbally with  
Pharmacy staff. See Figure 5. Australasian Medical Journal 2009,1,2 
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Figure 5. Ease of completion of questionnaire 
Discussion 
The symptomatic presentation of community pharmacy customers who request over 
the counter treatment for haemorrhoids as determined in this study demonstrates that 
many may not be presenting simply with haemorrhoids. The high incidence of rectal 
bleeding, altered bowel habit, abdominal pain and unexplained weight loss, 
particularly when they occur in the same patient, suggests that there are several 
occasions when a community pharmacist may need to refer a customer for a medical 
consultation. A detailed history of these symptoms is required to make an appropriate 
judgement on whether to treat or refer a patient, for example the amount of blood 
noticed by the customer may suggest a significant colorectal lesion, or the colour of 
blood may indicate bleeding further up the gastrointestinal tract.
15 
Also of particular concern is the prolonged duration of symptoms, with many clients 
apparently waiting for months before seeking advice. 50.1% of respondents with 
rectal bleeding, 33.3% of respondents with altered bowel habit and 33.3% of 
respondents with local anorectal symptoms indicated that these symptoms had 
persisted for over six months. Because the prognosis for many diseases, including 
colorectal cancer, worsens with late diagnosis, it is important that people are 
encouraged to seek advice sooner. What was not evaluated in this study was whether 
clients had tried treatments for these symptoms in the past. It is possible that some Australasian Medical Journal 2009,1,2 
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clients have been presenting regularly and have been self-medicating for long periods 
without success, in which case urgent referral is indicated. 
A number of clients who completed this questionnaire indicated that they took some 
form of regular medication. These people are likely to visit their local community 
pharmacy on a regular basis to obtain supplies, thus there is an opportunity to advice 
people who present with symptoms but may not consider it important to seek the 
advice of a doctor. In addition, several medications mentioned specifically in the 
questionnaire will have a bearing on cancer risk.
28, 29 
It also appears that a screening tool such as this questionnaire would be largely 
acceptable to clients if implemented in a community setting. Customer satisfaction 
with the questionnaire was high, with people reporting the exercise both easy and 
unobtrusive. One issue that may require further consideration however is the question 
of privacy. What this study did not address was how many of the respondents were 
actually given the opportunity to complete the survey in a private area, as it was 
observed that very few pharmacies have dedicated private spaces, and of those that 
do, the extent to which they are used is unclear. However the majority of customers 
reported being more comfortable completing written questionnaires about 
embarrassing symptoms than discussing symptoms verbally with pharmacy staff.  
It was also found that the majority of respondents (68.9%) would agree to allow the 
community pharmacist to pass copies of the completed surveys to their general 
practitioners if they felt that a medical consultation was required. There is therefore 
the potential for a more formalised referral system to be established between the 
community pharmacist and the general practitioner, especially given the increasing 
role of the pharmacist into the provision of primary health care. This preliminary 
study suggests that clients would be happy for liaison between health care 
professionals to occur, including a formal referral process, where appropriate. 
However, I urge caution when interpreting these results in view of the potential for 
bias given the limited response rate and lack of information about the attitudes of non-
responders. 
 Australasian Medical Journal 2009,1,2 
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Conclusions 
 
The symptomatic profiles of clients who present with anorectal symptoms suggest 
that there is a significant proportion that may benefit from pharmacist intervention 
and referral, to rule out potentially serious underlying conditions such as colorectal 
cancer. Responses from participants also suggest that the questionnaire model for 
obtaining symptomatic information from customers is a useful and acceptable format 
within a community pharmacy setting. 
Further research is needed to determine what proportion of community pharmacy 
customers that request haemorrhoid treatment are diagnosed with colorectal cancer or 
other colorectal conditions. 
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